- Edward Abraham, Wake Forest School of Medicine
- Zhinan Chen, Fourth Military Medical University
- Francesco Marincola, National Institutes of Health
- Xiangdong Wang, Fudan University
- Elias Zerhouni, Johns Hopkins University School of Medicine
Clinical and Translational Medicine is affiliated with the International Society for Translational Medicine.
Aims & scope
Clinical and Translational Medicine (CTM) aims to play an important and recognized role in reporting knowledge that contributes towards the understanding of molecular mechanisms of disease. CTM also aims to foster a predictive, preventive, personalized and practical approach towards precision medicine, leading to improved patient prognosis. The journal provides a forum for exchange of ideas between basic and clinical scientists on molecular and cellular mechanisms of disease and potential therapies.
The journal covers all areas of clinical and translational medicine but also has several special sections:
- Clinical Genomics- Edited by Olaf A. Bodamer and Gilbert S. Omenn
- Clinical and Translational Cardiovascular Medicine- Edited by Yong-Xiao Wang
- Translational Respiratory Medicine- Edited by Chunxue Bai
The section Translational Respiratory Medicine publishes contributions from clinicians and academics working within any sector with translational potentials between basic research and clinical application, on pathology, immunology and omics science to investigating respiratory and respiratory-related diseases. The section is devoted to the publication of high quality original papers, review articles, and case reports. The section provides a forum for exchange of ideas on potential molecular and cellular mechanisms of respiratory diseases. The section aims to play an important, critical, and recognized role in the understanding of human respiratory diseases and improvement of the prognosis of patients.
- Stem Cell Therapies- Edited by Mariusz Z. Ratajczak
The section on Stem Cell Therapies is focused on experimental and clinical results of stem cell therapies, stem cell isolation and expansion and is mainly interested in stem cells isolated or derived from adult tissues, umbilical cord blood, umbilical cord and placenta. It also covers mechanisms that regulate stem cell trafficking, including their mobilization into peripheral blood and homing to the damaged tissues. It also addresses molecular mechanisms involved in stem cell pluripotency, quiescence, proliferation and differentiation. Moreover, it deals with paracrine- and extracellular microvesicles-mediated effects of stem cell therapies, clinical ethics, regulations, trials, protocols, and practices of stem cell therapies in regenerative medicine.
For the full Section Boards, please see here.
SpringerOpen is Springer’s new suite of open access journals which will cover all disciplines. SpringerOpen journals are fully and immediately open access and will publish articles under the Creative Commons Attribution license. This makes it easy for authors to fully comply with open access mandates and retain copyright. SpringerOpen journals combine open access and our expertise in delivering high-quality and rapid publications, from online submission systems and in-depth peer review to an efficient, author-friendly production process.